Logo





  About us
  Advertising
  Privacy
  Terms
  Directory
  Submit Feed
  Analytics
  Trending
  Bias
  Trust Ranking
  API

Wall Street Journal // Business

23andMe Lays Off 40% of Staff, Shuts Drug Development Business

Tuesday 12th November 2024, 3:20AM

The genetics company is closing a unit that was once seen as core to its future.

Full Story